Abstract |
A randomised, double-blind, placebo-controlled trial with lithium succinate ointment was conducted in patients with AIDS-associated facial seborrhoeic dermatitis. Twice daily applications of the ointment brought about a rapid (2.5 days) and highly significant (P = 0.007) improvement in the severity of the condition. Lithium succinate ointment is well tolerated and can be a useful treatment for seborrhoeic dermatitis in this group of patients.
|
Authors | J A Langtry, C M Rowland Payne, R C Staughton, J C Stewart, D F Horrobin |
Journal | Clinical and experimental dermatology
(Clin Exp Dermatol)
Vol. 22
Issue 5
Pg. 216-9
(Sep 1997)
ISSN: 0307-6938 [Print] England |
PMID | 9536541
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Dermatologic Agents
- Lithium Compounds
- Ointments
|
Topics |
- Acquired Immunodeficiency Syndrome
(complications)
- Dermatitis, Seborrheic
(drug therapy, etiology)
- Dermatologic Agents
(therapeutic use)
- Double-Blind Method
- Facial Dermatoses
(drug therapy, etiology)
- Humans
- Lithium Compounds
(therapeutic use)
- Male
- Ointments
- Treatment Outcome
|